Results from the ODAK FP7 project have helped leading international ophthalmic company SIFI, take AKANTIOR® closer to becoming the first approved orphan medicinal product for the rare infectious eye disease - Acanthamoeba keratitis.

In June SIFI announced the European Medicines Agency (EMA) has validated its Marketing Authorization Application for AKANTIOR® (polihexanide) for the treatment of acanthamoeba keratitis (AK). Professor John Dart, the pivotal Phase III clinical trial principal investigator and Honorary Clinical Professor at the Institute of Ophthalmology, University College London, stated, “AK is one of the most severe and painful eye infections and also one for which there is no licensed therapy. Most patients require months of treatment and 25% lose useful vision. Our 15 year drug development project culminated in October 2021 with the completion of the Phase III clinical trial which has demonstrated a high medical cure rate. Our findings show that AKANTIOR® will provide a majority of AK patients the prospect of recovering their vision and quality of life; I hope that this will soon become the standard of care for treatment of this disease.” 

SIFI are aiming to commercially launch AKANTIOR® across Europe,  by 2023, and is proactively launching a pan-European early access program to enable access for patients to AKANTIOR® without delay.  

Read more: 

Latest Factsheet         ODAK Brochure          AK Awareness flyer

Or visit our YouTube channel

 

Innovation & Research Strategy

Innovation & Research Strategy

We bring independent thinking and insight to help clients develop and refine excellent research proposals and business plans...

FIND OUT MORE

Funding

Funding

We have been successful in multiple EU and UK funding applications and can provide help and advice about the suitability of your research plans for National and European...

FIND OUT MORE

Project Management

Project Management

Successful projects require a focused approach to project management. Our experienced professionals can provide management support to...

FIND OUT MORE

Communication

Communication

Scientific advances influence almost all parts of society, so scientists and the research community have a duty to communicate research results...

FIND OUT MORE

Exploitation & Impact

Exploitation & Impact

Demonstrating the impact of research is now critical to modern projects and forms a key criterion of proposal evaluation...

FIND OUT MORE

Training

Training

Our aim is to help you understand grant funding, learn the key elements of a winning proposal and how to manage a collaborative project...

FIND OUT MORE